Squawk on the Street

Cramer's Morning Take: Bristol Myers 12/16/24

Dec 16, 2024

Discover the excitement behind Bristol-Myers' stock surge thanks to promising drug developments like Cobenphie for schizophrenia. The discussion highlights impressive sales projections and the company's attractive dividend yield. A disciplined approach to investments is emphasized, encouraging selective decision-making amid market dips. Join the conversation about navigating the challenges of the current market landscape while seizing potential opportunities.

03:28

Creator website

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Walmart Express provides rapid delivery, aiming to ease holiday stress for customers with orders arriving in as little as one hour.

Bristol-Myers is gaining investor attention due to its promising schizophrenia drug, highlighting the need for strategic investment amid market downturns.

Deep dives

Walmart Express Delivery During the Holidays

Walmart Express offers quick delivery services, ensuring that customers can receive their orders in as little as an hour during the busy holiday season. This rapid delivery option is especially convenient on Christmas Eve, with a cutoff time for orders set at 4 p.m. local time. Despite the last-minute rush that often accompanies holiday shopping, Walmart aims to alleviate stress for its customers by providing a reliable and efficient service. This approach allows individuals and families to enjoy the festivities without worrying about last-minute shopping tasks.

Intro

2min

Optimistic Investment in Bristol-Myers and Its Growth Potential

2min

A Disciplined Approach to Investment Strategies

2min

Cramer explains why the Club bought more of this pharma stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

CNBC Investing Club Disclaimer